Chinese regulators approve Sorenson's portable pain therapy pump:
This article was originally published in Clinica
Chinese regulators have given Sorenson Medical approval to market its ambulatory infusion pump for managing pain. The ambIT PCA (patient controlled analgesia) device is a lightweight, battery-operated product that enables patients to go about their normal lives as they receive pain treatment, while reducing the risk of side effects and addiction from narcotic drugs, said the West Jordan, Utah firm. It will be distributed locally by Pharmamedic, a Hong Kong-based subsidiary of South Asia Group Holding.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.